Kyttälä et al., 2016 - Google Patents
Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potentialKyttälä et al., 2016
View HTML- Document ID
- 5560059064198721581
- Author
- Kyttälä A
- Moraghebi R
- Valensisi C
- Kettunen J
- Andrus C
- Pasumarthy K
- Nakanishi M
- Nishimura K
- Ohtaka M
- Weltner J
- Van Handel B
- Parkkonen O
- Sinisalo J
- Jalanko A
- Hawkins R
- Woods N
- Otonkoski T
- Trokovic R
- Publication year
- Publication venue
- Stem cell reports
External Links
Snippet
Reports on the retention of somatic cell memory in induced pluripotent stem cells (iPSCs) have complicated the selection of the optimal cell type for the generation of iPSC biobanks. To address this issue we compared transcriptomic, epigenetic, and differentiation …
- 230000004069 differentiation 0 title abstract description 41
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kyttälä et al. | Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential | |
Messmer et al. | Transcriptional heterogeneity in naive and primed human pluripotent stem cells at single-cell resolution | |
Wu et al. | Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics | |
Bredenkamp et al. | The cell-surface marker sushi containing domain 2 facilitates establishment of human naive pluripotent stem cells | |
Ding et al. | Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm | |
Panopoulos et al. | iPSCORE: a resource of 222 iPSC lines enabling functional characterization of genetic variation across a variety of cell types | |
Schulz et al. | A unique epigenomic landscape defines human erythropoiesis | |
Salomonis et al. | Integrated genomic analysis of diverse induced pluripotent stem cells from the progenitor cell biology consortium | |
Chen et al. | Spatial genome re-organization between fetal and adult hematopoietic stem cells | |
Shan et al. | JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells | |
Caron et al. | A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles | |
Polo et al. | Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells | |
Urbach et al. | Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | |
Lee et al. | Modeling familial cancer with induced pluripotent stem cells | |
Abell et al. | MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells | |
Guo et al. | Nonstochastic reprogramming from a privileged somatic cell state | |
Nazor et al. | Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives | |
Cahan et al. | Origins and implications of pluripotent stem cell variability and heterogeneity | |
Shao et al. | Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles | |
Neveu et al. | MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states | |
Mills et al. | NIPBL+/− haploinsufficiency reveals a constellation of transcriptome disruptions in the pluripotent and cardiac states | |
Senft et al. | Combinatorial Smad2/3 activities downstream of nodal signaling maintain embryonic/extra-embryonic cell identities during lineage priming | |
Nakatake et al. | Generation and profiling of 2,135 human ESC lines for the systematic analyses of cell states perturbed by inducing single transcription factors | |
Stelzer et al. | Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells | |
Szczerbinska et al. | A chemically defined feeder-free system for the establishment and maintenance of the human naive pluripotent state |